litlas
Log inCreate account

Philippe Gevaert

Active 2000–2025

125
Papers
26,545
Citations
78
h-index
123
i10-index

Citations

Citations per year for Philippe Gevaert1976: 1 citations1987: 1 citations1990: 1 citations1996: 1 citations1997: 1 citations1999: 1 citations2001: 3 citations2002: 4 citations2003: 16 citations2004: 46 citations2005: 21 citations2006: 49 citations2007: 57 citations2008: 76 citations2009: 104 citations2010: 131 citations2011: 120 citations2012: 146 citations2013: 142 citations2014: 161 citations2015: 211 citations2016: 242 citations2017: 186 citations2018: 257 citations2019: 878 citations2020: 1,117 citations2021: 970 citations2022: 890 citations2023: 791 citations2024: 957 citations2025: 400 citations2026: 6 citations1977–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown1991–1995: no citations, so these years are not shown1998: no citations, so this year is not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,210 citing papers, 14.2% of this breakdownChina: 556 citing papers, 6.6% of this breakdownUnited Kingdom: 518 citing papers, 6.1% of this breakdownItaly: 492 citing papers, 5.8% of this breakdownGermany: 454 citing papers, 5.4% of this breakdownBelgium: 428 citing papers, 5% of this breakdownSpain: 366 citing papers, 4.3% of this breakdownNetherlands: 317 citing papers, 3.7% of this breakdownFrance: 299 citing papers, 3.5% of this breakdownAustralia: 245 citing papers, 2.9% of this breakdownSweden: 241 citing papers, 2.8% of this breakdownJapan: 239 citing papers, 2.8% of this breakdown
0%14.2%Other 36.9%

Institutions

Fields

  • Medicine85.2%
  • Immunology and Microbiology5.2%
  • Neuroscience3.5%
  • Biochemistry, Genetics and Molecular Biology1.8%
  • Health Professions1.1%
  • Nursing0.8%
  • Other2.4%

Topics

  • Sinusitis and nasal conditions17.5%
  • Allergic Rhinitis and Sensitization16.5%
  • Asthma and respiratory diseases14.7%
  • Nasal Surgery and Airway Studies5.5%
  • Olfactory and Sensory Function Studies3.3%
  • Respiratory and Cough-Related Research2.9%
  • Other39.6%

Coauthors

All papers

Open in search
  1. European Position Paper on Rhinosinusitis and Nasal Polyps 2020

    Authors: W.J. Fokkens, Valerie J. Lund, C. Hopkins, Peter W. Hellings, Robert C. Kern, Sietze Reitsma, Sanna Toppila‐Salmi, Manuel Bernal‐Sprekelsen, J Mullol, Isam Alobid, Wilma Terezinha Anselmo‐Lima, Claus Bachert, Fuad M. Baroody, Christian von Buchwald, Anders Cervin, Natalie R. Cohen, J. Constantinidis, L. de Gabory, Martin Desrosiers, Zuzana Diamant, Richard Douglas, Philippe Gevaert, Anne‐Sophie Hafner, Richard J. Harvey, Guy Joos, Livije Kalogjera, Andrew Knill, Janwillem Kocks, Basile N. Landis, Jacqueline Limpens, Sarah Lebeer, Olga Lourenço, P.M. Matricardi, Cem Meço, Liam O’Mahony, Carl Philpott, Dermot Ryan, Ralf G.M. Schlösser, Brent A. Senior, Timothy L. Smith, Thijs Teeling, Peter Valentin Tomazic, D.Y. Wang, De Yun Wang, L Zhang, Adrian M. Agius, Cecilia Ahlström‐Emanuelsson, Rashid bin Yahya Al-Abri, Silviu Albu, Saied Alhabash, Aleksandra Aleksić, Mohammad Aloulah, Mohannad Al‐Qudah, Saad Alsaleh, Muaid I. Aziz Baban, Tomislav Baudoin, T Balvers, Paolo Battaglia, David Bedoya, Achim G. Beule, Khaled Mohamed Bofares, Irwin M. Braverman, Eliza Brożek-Mądry, B Richard, C. A. Callejas, Sean Carrie, Lisa Caulley, Desderius Chussi, Eugenio De Corso, A. Coste, L. Devyani, Usamah Hadi, Ahmaed Elfarouk, P.H. Eloy, Shokrollah Farrokhi, Giovanni Felisati, M.D. Ferrari, Roman Fishchuk, J.W. Grayson, P.M. Goncalves, Boris Grdinić, V Grgic, A.W. Hamizan, J.V. Heinichen, Salina Husain, T.I. Ping, Justinas Ivaška, Frodita Jakimovska, Ljiljana Jovančević, Emily Kakande, Rasha Kamel, Sergey Karpischenko, H.H. Kariyawasam, Jens Kjeldsen, L. Klimek, S.W. Kim, J.J. Letort, Lopatin As, A Mahdjoubi, J Netkovski and 48 more - Rhinology Journal 2020 cited by 5,501

  2. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

    Authors: Philippe Gevaert, Theodore A. Omachi, Jonathan Corren, Joaquim Mullol, Joseph K. Han, Stella E. Lee, Derrick Kaufman, Monica Ligueros‐Saylan, Monet Howard, Rui Zhu, Ryan Owen, Kit Wong, Lutaf Islam, Claus Bachert - Journal of Allergy and Clinical Immunology 2020 cited by 697

  3. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

    Authors: W.J. Fokkens, A-S Viskens, V. Backer, Diego M. Conti, E De Corso, Philippe Gevaert, G K Scadding, M. Wagemann, Manuel Bernal‐Sprekelsen, Adam Chaker, Enrico Heffler, Jianjun Han, E Van Staeyen, C Hopkins, J Mullol, Aaron W. Peters, Sietze Reitsma, Brent A. Senior, Peter W. Hellings - Rhinology Journal 2023 cited by 268

  4. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

    Authors: Claus Bachert, J Han, Martin Wagenmann, W. Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert, Ludger Klimek, E Prokopakis, Andrew Knill, Carlo Cavaliere, Claire Hopkins, Peter W. Hellings - Journal of Allergy and Clinical Immunology 2020 cited by 348

  5. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

    Authors: Claus Bachert, Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert, Enrico Heffler, Claire Hopkins, Jody Tversky, Peter Barker, David Cohen, Claire Emson, Ubaldo J. Martin, Vivian H. Shih, Sofia Necander, James L. Kreindler, Maria Jison, Viktoría Werkström - Journal of Allergy and Clinical Immunology 2021 cited by 307

  6. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

    Authors: Claus Bachert, Leda Mannent, Robert M. Naclerio, Joaquim Mullol, Berrylin J. Ferguson, Philippe Gevaert, Peter W. Hellings, Lixia Jiao, Lin Wang, Robert R. Evans, Gianluca Pirozzi, Neil M.H. Graham, Brian N. Swanson, Jennifer D. Hamilton, Allen Radin, Namita A. Gandhi, Neil Stahl, George D. Yancopoulos, E. Rand Sutherland - JAMA 2016 cited by 785

  7. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

    Authors: Wytske J. Fokkens, Valerie Lund, Joaquim Mullol, Claus Bachert, Isam Alobid, Fuad M. Baroody, Noam A. Cohen, Anders Cervin, Richard Douglas, Philippe Gevaert, C. Georgalas, H. Goossens, Richard J. Harvey, Peter W. Hellings, Claire Hopkins, Nicholas S. Jones, Guy Joos, Livije Kalogjera, Benjamin Kern, M. L. Kowalski, David Price, Herbert Riechelmann, Rodney J. Schlosser, Brent A. Senior, Mike Thomas, Е. Тоскала, Richard Louis Voegels, D.Y. Wang, P. ‐J. Wormald - Rhinology Journal 2012 cited by 2,409

  8. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

    Authors: Claus Bachert, Ana R. Sousa, Valerie Lund, Glenis Scadding, Philippe Gevaert, Shuaib Nasser, Stephen R. Durham, Marjolein Cornet, Harsha H. Kariyawasam, Jane Gilbert, Daren Austin, Aoife C. Maxwell, Richard P. Marshall, Wytske J. Fokkens - Journal of Allergy and Clinical Immunology 2017 cited by 505

  9. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

    Authors: Philippe Gevaert, Lien Calus, Thibaut Van Zele, Katrien Blomme, Natalie De Ruyck, Wouter Bauters, Peter W. Hellings, Guy Brusselle, Dirk De Bacquer, Paul Van Cauwenberge, Claus Bachert - Journal of Allergy and Clinical Immunology 2012 cited by 744

  10. The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps

    Authors: Philippe Gevaert, Joseph K. Han, Steven G. Smith, Ana R. Sousa, Peter Howarth, Steven W. Yancey, Robert Chan, Claus Bachert - International Forum of Allergy & Rhinology 2022 cited by 129

  11. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis

    Authors: Lien Calus, Nicholas Van Bruaene, Cédric Bosteels, Sarah Dejonckheere, Thibaut Van Zele, Gabrielle Holtappels, Claus Bachert, Philippe Gevaert - Clinical and Translational Allergy 2019 cited by 208

  12. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

    Authors: Philippe Gevaert, Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, Lutaf Islam, Monica Ligueros‐Saylan, Theodore A. Omachi, Claus Bachert - Journal of Allergy and Clinical Immunology 2021 cited by 122

  13. European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

    Authors: Philippe Gevaert, Jarno De Craemer, Claus Bachert, Manon Blauwblomme, Adam Chaker, Cemal Cingi, Peter W. Hellings, Claire Hopkins, Valérie Hox, Wytske J. Fokkens, Ludger Klimek, Valerie Lund, Ralph Mösges, Joaquim Mullol, Oliver Pfaar, Glenis Scadding, Peter Valentin Tomazic, Thibaut Van Zele, Stephan Vlaminck, Martin Wagenmann, Sanna Toppila‐Salmi, Isam Alobid - Allergy 2023 cited by 76

  14. Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

    Authors: Philippe Gevaert, Nicholas Van Bruaene, Tom Cattaert, Kristel Van Steen, Thibaut Van Zele, Frederic Acke, Natalie De Ruyck, Katrien Blomme, Ana R. Sousa, Richard P. Marshall, Claus Bachert - Journal of Allergy and Clinical Immunology 2011 cited by 624

  15. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

    Authors: Valérie Hox, Evelijn Lourijsen, Arnout Jordens, Kristian Aasbjerg, Ioana Agache, Isam Alobid, Claus Bachert, Koen Boussery, Paloma Campo, Wytske J. Fokkens, Peter W. Hellings, Claire Hopkins, Ludger Klimek, Mika J. Mäkelä, Ralph Mösges, Joaquim Mullol, Laura Pujols, Carmen Rondón, Michael Rudenko, Sanna Toppila‐Salmi, Glenis Scadding, Sophie Scheire, Peter Valentin Tomazic, Thibaut Van Zele, Martin Wagenmann, Job F. M. van Boven, Philippe Gevaert - Clinical and Translational Allergy 2020 cited by 186

  16. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps

    Authors: Joaquim Mullol, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joseph K. Han, R. Jankowski, Jan Vodička, Philippe Gevaert, Nadia Daizadeh, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 100

  17. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Authors: Pascal Demoly, Jonathan Corren, Peter S. Creticos, F. de Blay, Philippe Gevaert, Peter W. Hellings, Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, Oliver Pfaar, Miguel Tortajada‐Girbés, Carmen Vidal, Margitta Worm, Thomas B. Casale - Journal of Allergy and Clinical Immunology 2020 cited by 95

  18. Differentiation of chronic sinus diseases by measurement of inflammatory mediators

    Authors: Thibaut Van Zele, Sofie Claeys, Philippe Gevaert, Georges Van Maele, Gabriële Holtappels, Paul Van Cauwenberge, Claus Bachert - Allergy 2006 cited by 779

  19. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

    Authors: Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joaquim Mullol, Jorge Máspero, Philippe Gevaert, Mei Zhang, Xuezhou Mao, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent - Annals of Allergy Asthma & Immunology 2021 cited by 104

  20. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP

    Authors: Wytske J. Fokkens, Eugenio De Corso, Vibeke Backer, Manuel Bernal‐Sprekelsen, Leif Bjermer, Christian von Buchwald, Adam Chaker, Zuzana Diamant, Philippe Gevaert, Jiangli Han, Claire Hopkins, Valérie Hox, Ludger Klimek, Valerie Lund, S Lee, Annie Luong, Joaquim Mullol, Anju T. Peters, Oliver Pfaar, Sietze Reitsma, Sanna Toppila‐Salmi, Glenis Scadding, Ahmad R. Sedaghat, A-S Viskens, Martin Wagenmann, Peter W. Hellings - Rhinology Journal 2024 cited by 82

  21. EAACI Position paper on the standardization of nasal allergen challenges

    Authors: Josep M. Augé, Julia Vent, Ioana Agache, Liisa Airaksinen, Paloma Campo Mozo, Adam Chaker, Cemal Cingi, Stephen R. Durham, W.J. Fokkens, Philippe Gevaert, Aris Ι. Giotakis, Peter W. Hellings, Magdalena Herknerová, Valérie Hox, Ludger Klimek, C. Meliá, Joaquim Mullol, Nuray Bayar Muluk, Antonella Muraro, Keisuke Naito, Oliver Pfaar, Herbert Riechelmann, Carmen Rondón, Michael Rudenko, Bolesław Samoliński, Ignazio Tasca, Peter Valentin Tomazic, Klaus Vogt, Martin Wagenmann, Galyna Yeryomenko, Luo Zhang, Ralph Mösges - Allergy 2018 cited by 264

  22. The Importance of Local Eosinophilia in the Surgical Outcome of Chronic Rhinosinusitis: A 3-Year Prospective Observational Study

    Authors: Stephan Vlaminck, Tom Vauterin, Peter W. Hellings, Mark Jorissen, Frederic Acke, Paul Van Cauwenberge, Claus Bachert, Philippe Gevaert - American Journal of Rhinology and Allergy 2014 cited by 206

  23. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps

    Authors: Anju T. Peters, Joseph K. Han, Peter W. Hellings, Enrico Heffler, Philippe Gevaert, Claus Bachert, Yingxin Xu, Chien‐Chia Chuang, Binod Neupane, Jérôme Msihid, Leda Mannent, Patricia Guyot, Siddhesh Kamat - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 97

  24. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up

    Authors: Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter W. Hellings, Joseph K. Han, Anju T. Peters, Jared Silver, Steven G. Smith, Abigail Fuller, Ana R. Sousa, Robert Chan, Philippe Gevaert, the SYNAPSE study investigators - International Forum of Allergy & Rhinology 2023 cited by 33